Skip to main content
Top
Published in: Diabetologia 10/2004

01-10-2004 | Article

Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor

Authors: A. W. Stitt, S.-J. Hughes, P. Canning, O. Lynch, O. Cox, N. Frizzell, S. R. Thorpe, T. G. Cotter, T. M. Curtis, T. A. Gardiner

Published in: Diabetologia | Issue 10/2004

Login to get access

Abstract

Aims/hypothesis

Premature death of retinal pericytes is a pathophysiological hallmark of diabetic retinopathy. Among the mechanisms proposed for pericyte death is exposure to AGE, which accumulate during diabetes. The current study used an in vitro model, whereby retinal pericytes were exposed to AGE-modified substrate and the mechanisms underlying pericyte death explored.

Methods

Pericytes were isolated from bovine retinal capillaries and propagated on AGE-modified basement membrane (BM) extract or non-modified native BM. The extent of AGE modification was analysed. Proliferative responses of retinal pericytes propagated on AGE-modified BM were investigated using a 5-bromo-2-deoxy-uridine-based assay. The effect of extrinsically added platelet-derived growth factor (PDGF) isoforms on these proliferative responses was also analysed alongside mRNA expression of the PDGF receptors. Apoptotic death of retinal pericytes grown on AGE-modified BM was investigated using terminal deoxynucleotidyl transferase-mediated dUTP nick end-labelling labelling, mitochondrial membrane depolarisation and by morphological assessment. We also measured both the ability of PDGF to reverse Akt dephosphorylation that was mediated by AGE-modified BM, and increased pericyte apoptosis.

Results

Retinal pericytes exposed to AGE-modified BM showed reduced proliferative responses in comparison to controls (p<0.05–0.01), although this effect was reversed at low-AGE modifications. PDGF mRNA levels were differentially altered by exposure to low and high AGE levels, and AGE-modified BM caused significantly increased apoptosis in retinal pericytes. Pre-treatment of AGE-modified BM with PDGF-AA and -BB reversed the apoptosis (p<0.05–0.001) and restored Akt phosphorylation in retinal pericytes.

Conclusions/interpretation

Evidence suggests that substrate-derived AGE such as those that occur during diabetes could have a major influence on retinal pericyte survival. During diabetic retinopathy, AGE modification of vascular BM may reduce bioavailability of pro-survival factors for retinal pericytes.
Literature
1.
2.
go back to reference Wu DM, Kawamura H, Sakagami K, Kobayashi M, Puro DG (2003) Cholinergic regulation of pericyte-containing retinal microvessels. Am J Physiol Heart Circ Physiol 284:H2083–H2090PubMed Wu DM, Kawamura H, Sakagami K, Kobayashi M, Puro DG (2003) Cholinergic regulation of pericyte-containing retinal microvessels. Am J Physiol Heart Circ Physiol 284:H2083–H2090PubMed
3.
go back to reference Kelley C, D’Amore P, Hechtman HB, Shepro D (1987) Microvascular pericyte contractility in vitro: comparison with other cells of the vascular wall. J Cell Biol 104:483–490CrossRefPubMed Kelley C, D’Amore P, Hechtman HB, Shepro D (1987) Microvascular pericyte contractility in vitro: comparison with other cells of the vascular wall. J Cell Biol 104:483–490CrossRefPubMed
4.
go back to reference D’Amore PA, Smith SR (1993) Growth factor effects on cells of the vascular wall: a survey. Growth Factors 8:61–75PubMed D’Amore PA, Smith SR (1993) Growth factor effects on cells of the vascular wall: a survey. Growth Factors 8:61–75PubMed
5.
go back to reference Garner A (1993) Histopathology of diabetic retinopathy in man. Eye 7:250–253PubMed Garner A (1993) Histopathology of diabetic retinopathy in man. Eye 7:250–253PubMed
6.
go back to reference Li W, Yanoff M, Liu X, Ye X (1997) Retinal capillary pericyte apoptosis in early human diabetic retinopathy. Chin Med J (Engl) 110:659–663 Li W, Yanoff M, Liu X, Ye X (1997) Retinal capillary pericyte apoptosis in early human diabetic retinopathy. Chin Med J (Engl) 110:659–663
7.
go back to reference Podesta F, Romeo G, Liu WH et al. (2000) Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am J Pathol 156:1025–1032PubMed Podesta F, Romeo G, Liu WH et al. (2000) Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am J Pathol 156:1025–1032PubMed
8.
go back to reference Kern TS, Tang J, Mizutani M et al. (2000) Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci 41:3972–3978PubMed Kern TS, Tang J, Mizutani M et al. (2000) Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci 41:3972–3978PubMed
9.
go back to reference Murata M, Ohta N, Fujisawa S et al. (2002) Selective pericyte degeneration in the retinal capillaries of galactose-fed dogs results from apoptosis linked to aldose reductase-catalyzed galactitol accumulation. J Diabetes Complications 16:363–370CrossRefPubMed Murata M, Ohta N, Fujisawa S et al. (2002) Selective pericyte degeneration in the retinal capillaries of galactose-fed dogs results from apoptosis linked to aldose reductase-catalyzed galactitol accumulation. J Diabetes Complications 16:363–370CrossRefPubMed
10.
go back to reference Miwa K, Nakamura J, Hamada Y et al. (2003) The role of polyol pathway in glucose-induced apoptosis of cultured retinal pericytes. Diabetes Res Clin Pract 60:1–9CrossRefPubMed Miwa K, Nakamura J, Hamada Y et al. (2003) The role of polyol pathway in glucose-induced apoptosis of cultured retinal pericytes. Diabetes Res Clin Pract 60:1–9CrossRefPubMed
11.
go back to reference Yamagishi S, Amano S, Inagaki Y et al. (2002) Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes. Biochem Biophys Res Commun 290:973–978CrossRefPubMed Yamagishi S, Amano S, Inagaki Y et al. (2002) Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes. Biochem Biophys Res Commun 290:973–978CrossRefPubMed
12.
go back to reference Stitt AW, Jenkins AJ, Cooper ME (2002) Advanced glycation end products and diabetic complications. Expert Opin Investig Drugs 11:1205–1223PubMed Stitt AW, Jenkins AJ, Cooper ME (2002) Advanced glycation end products and diabetic complications. Expert Opin Investig Drugs 11:1205–1223PubMed
13.
go back to reference Hammes HP (2003) Pathophysiological mechanisms of diabetic angiopathy. J Diabetes Complications 17:16–19 Hammes HP (2003) Pathophysiological mechanisms of diabetic angiopathy. J Diabetes Complications 17:16–19
14.
go back to reference Baynes JW, Thorpe SR (2000) Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 28:1708–1716CrossRefPubMed Baynes JW, Thorpe SR (2000) Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 28:1708–1716CrossRefPubMed
15.
go back to reference Stitt AW, Li YM, Gardiner TA, Bucala R, Archer DB, Vlassara H (1997) Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J Pathol 150:523–531PubMed Stitt AW, Li YM, Gardiner TA, Bucala R, Archer DB, Vlassara H (1997) Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J Pathol 150:523–531PubMed
16.
go back to reference Stitt A, Gardiner TA, Alderson NL et al. (2002) The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51:2826–2832PubMed Stitt A, Gardiner TA, Alderson NL et al. (2002) The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51:2826–2832PubMed
17.
go back to reference Hammes HP, Alt A, Niwa T et al. (1999) Differential accumulation of advanced glycation end products in the course of diabetic retinopathy. Diabetologia 42:728–736CrossRefPubMed Hammes HP, Alt A, Niwa T et al. (1999) Differential accumulation of advanced glycation end products in the course of diabetic retinopathy. Diabetologia 42:728–736CrossRefPubMed
19.
go back to reference Cardone MH, Roy N, Stennicke HR et al. (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318–1321CrossRefPubMed Cardone MH, Roy N, Stennicke HR et al. (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318–1321CrossRefPubMed
20.
go back to reference Bailey AJ (2001) Molecular mechanisms of ageing in connective tissues. Mech Ageing Dev 122:735–755CrossRefPubMed Bailey AJ (2001) Molecular mechanisms of ageing in connective tissues. Mech Ageing Dev 122:735–755CrossRefPubMed
21.
go back to reference Chakravarthy U, Gardiner TA (1999) Endothelium-derived agents in pericyte function/dysfunction. Prog Retin Eye Res 18:511–527CrossRefPubMed Chakravarthy U, Gardiner TA (1999) Endothelium-derived agents in pericyte function/dysfunction. Prog Retin Eye Res 18:511–527CrossRefPubMed
22.
go back to reference Hart CE, Forstrom JW, Kelly JD et al. (1988) Two classes of PDGF receptor recognize different isoforms of PDGF. Science 240:1529–1531PubMed Hart CE, Forstrom JW, Kelly JD et al. (1988) Two classes of PDGF receptor recognize different isoforms of PDGF. Science 240:1529–1531PubMed
23.
go back to reference Matsui T, Pierce JH, Fleming TP et al. (1989) Independent expression of human alpha or beta platelet-derived growth factor receptor cDNAs in a naive hematopoietic cell leads to functional coupling with mitogenic and chemotactic signaling pathways. Proc Natl Acad Sci USA 86:8314–8318PubMed Matsui T, Pierce JH, Fleming TP et al. (1989) Independent expression of human alpha or beta platelet-derived growth factor receptor cDNAs in a naive hematopoietic cell leads to functional coupling with mitogenic and chemotactic signaling pathways. Proc Natl Acad Sci USA 86:8314–8318PubMed
24.
go back to reference Rosenkranz S, Kazlauskas A (1999) Evidence for distinct signaling properties and biological responses induced by the PDGF receptor alpha and beta subtypes. Growth Factors 16:201–216PubMed Rosenkranz S, Kazlauskas A (1999) Evidence for distinct signaling properties and biological responses induced by the PDGF receptor alpha and beta subtypes. Growth Factors 16:201–216PubMed
25.
go back to reference Lindahl P, Johansson BR, Leveen P, Betsholtz C (1997) Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277:242–245CrossRefPubMed Lindahl P, Johansson BR, Leveen P, Betsholtz C (1997) Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277:242–245CrossRefPubMed
26.
go back to reference Bostrom H, Willetts K, Pekny M et al. (1996) PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell 85:863–873CrossRefPubMed Bostrom H, Willetts K, Pekny M et al. (1996) PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell 85:863–873CrossRefPubMed
27.
go back to reference Soriano P (1994) Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev 8:1888–1896PubMed Soriano P (1994) Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev 8:1888–1896PubMed
28.
go back to reference Hammes HP, Lin J, Renner O et al. (2002) Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 51:3107–3112PubMed Hammes HP, Lin J, Renner O et al. (2002) Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 51:3107–3112PubMed
29.
go back to reference Enge M, Bjarnegard M, Gerhardt H et al. (2002) Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy. EMBO J 21:4307–4316CrossRefPubMed Enge M, Bjarnegard M, Gerhardt H et al. (2002) Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy. EMBO J 21:4307–4316CrossRefPubMed
30.
go back to reference Chakravarthy U, Stitt AW, McNally J, Bailie JR, Hoey EM, Duprex P (1995) Nitric oxide synthase activity and expression in retinal capillary endothelial cells and pericytes. Curr Eye Res 14:285–294PubMed Chakravarthy U, Stitt AW, McNally J, Bailie JR, Hoey EM, Duprex P (1995) Nitric oxide synthase activity and expression in retinal capillary endothelial cells and pericytes. Curr Eye Res 14:285–294PubMed
31.
go back to reference Yamagishi S, Yonekura H, Yamamoto Y et al. (1997) Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. J Biol Chem 272:8723–8730CrossRefPubMed Yamagishi S, Yonekura H, Yamamoto Y et al. (1997) Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. J Biol Chem 272:8723–8730CrossRefPubMed
32.
go back to reference Nagai R, Matsumoto K, Ling X, Suzuki H, Araki T, Horiuchi S (2000) Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes 49:1714–1723PubMed Nagai R, Matsumoto K, Ling X, Suzuki H, Araki T, Horiuchi S (2000) Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes 49:1714–1723PubMed
33.
go back to reference Shaw JN, Baynes JW, Thorpe SR (2002) N epsilon-(carboxymethyl)lysine (CML) as a biomarker of oxidative stress in long-lived tissue proteins. Methods Mol Biol 186:129–137CrossRefPubMed Shaw JN, Baynes JW, Thorpe SR (2002) N epsilon-(carboxymethyl)lysine (CML) as a biomarker of oxidative stress in long-lived tissue proteins. Methods Mol Biol 186:129–137CrossRefPubMed
34.
35.
go back to reference Simpson DA, Feeney S, Boyle C, Stitt AW (2000) Retinal VEGF mRNA measured by SYBR green I fluorescence: a versatile approach to quantitative PCR. Mol Vis 6:178–183PubMed Simpson DA, Feeney S, Boyle C, Stitt AW (2000) Retinal VEGF mRNA measured by SYBR green I fluorescence: a versatile approach to quantitative PCR. Mol Vis 6:178–183PubMed
36.
go back to reference Diaz G, Setzu MD, Zucca A et al. (1999) Subcellular heterogeneity of mitochondrial membrane potential: relationship with organelle distribution and intercellular contacts in normal, hypoxic and apoptotic cells. J Cell Sci 112:1077–1084PubMed Diaz G, Setzu MD, Zucca A et al. (1999) Subcellular heterogeneity of mitochondrial membrane potential: relationship with organelle distribution and intercellular contacts in normal, hypoxic and apoptotic cells. J Cell Sci 112:1077–1084PubMed
37.
go back to reference Hammes HP, Wellensiek B, Kloting I, Sickel E, Bretzel RG, Brownlee M (1998) The relationship of glycaemic level to advanced glycation end-product (AGE) accumulation and retinal pathology in the spontaneous diabetic hamster. Diabetologia 41:165–170CrossRefPubMed Hammes HP, Wellensiek B, Kloting I, Sickel E, Bretzel RG, Brownlee M (1998) The relationship of glycaemic level to advanced glycation end-product (AGE) accumulation and retinal pathology in the spontaneous diabetic hamster. Diabetologia 41:165–170CrossRefPubMed
38.
go back to reference Gardiner TA, Anderson HR, Stitt AW (2003) AGE-inhibition protects against retinal capillary basement membrane thickening during long-term diabetes. J Pathol 201:328–333CrossRefPubMed Gardiner TA, Anderson HR, Stitt AW (2003) AGE-inhibition protects against retinal capillary basement membrane thickening during long-term diabetes. J Pathol 201:328–333CrossRefPubMed
39.
go back to reference Cox O, Stitt AW, Simpson DA, Gardiner TA (2003) Sources of PDGF expression in murine retina and the effect of short-term diabetes. Mol Vis 10:665–672 Cox O, Stitt AW, Simpson DA, Gardiner TA (2003) Sources of PDGF expression in murine retina and the effect of short-term diabetes. Mol Vis 10:665–672
40.
go back to reference Degenhardt TP, Alderson NL, Arrington DD et al. (2002) Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney Int 61:939–950CrossRefPubMed Degenhardt TP, Alderson NL, Arrington DD et al. (2002) Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney Int 61:939–950CrossRefPubMed
41.
go back to reference Chibber R, Molinatti PA, Wong JS, Mirlees D, Kohner EM (1994) The effect of aminoguanidine and tolrestat on glucose toxicity in bovine retinal capillary pericytes. Diabetes 43:758–763PubMed Chibber R, Molinatti PA, Wong JS, Mirlees D, Kohner EM (1994) The effect of aminoguanidine and tolrestat on glucose toxicity in bovine retinal capillary pericytes. Diabetes 43:758–763PubMed
42.
go back to reference Ruggiero-Lopez D, Rellier N, Lecomte M, Lagarde M, Wiernsperger N (1997) Growth modulation of retinal microvascular cells by early and advanced glycation products. Diabetes Res Clin Pract 34:135–142CrossRefPubMed Ruggiero-Lopez D, Rellier N, Lecomte M, Lagarde M, Wiernsperger N (1997) Growth modulation of retinal microvascular cells by early and advanced glycation products. Diabetes Res Clin Pract 34:135–142CrossRefPubMed
43.
go back to reference Sharma NK, Gardiner TA, Archer DB (1985) A morphologic and autoradiographic study of cell death and regeneration in the retinal microvasculature of normal and diabetic rats. Am J Ophthalmol 100:51–60PubMed Sharma NK, Gardiner TA, Archer DB (1985) A morphologic and autoradiographic study of cell death and regeneration in the retinal microvasculature of normal and diabetic rats. Am J Ophthalmol 100:51–60PubMed
44.
go back to reference Denis U, Lecomte M, Paget C, Ruggiero D, Wiernsperger N, Lagarde M (2002) Advanced glycation end-products induce apoptosis of bovine retinal pericytes in culture: involvement of diacylglycerol/ceramide production and oxidative stress induction. Free Rad Biol Med 33:236–247CrossRefPubMed Denis U, Lecomte M, Paget C, Ruggiero D, Wiernsperger N, Lagarde M (2002) Advanced glycation end-products induce apoptosis of bovine retinal pericytes in culture: involvement of diacylglycerol/ceramide production and oxidative stress induction. Free Rad Biol Med 33:236–247CrossRefPubMed
45.
go back to reference Yamagishi S, Okamoto T, Amano S et al. (2002) Palmitate-induced apoptosis of microvascular endothelial cells and pericytes. Mol Med 8:179–184PubMed Yamagishi S, Okamoto T, Amano S et al. (2002) Palmitate-induced apoptosis of microvascular endothelial cells and pericytes. Mol Med 8:179–184PubMed
46.
go back to reference Yamagishi S, Amano S, Inagaki Y, Okamoto T, Takeuchi M, Makita Z (2002) Beraprost sodium, a prostaglandin I2 analogue, protects against advanced gycation end products-induced injury in cultured retinal pericytes. Mol Med 8:546–550PubMed Yamagishi S, Amano S, Inagaki Y, Okamoto T, Takeuchi M, Makita Z (2002) Beraprost sodium, a prostaglandin I2 analogue, protects against advanced gycation end products-induced injury in cultured retinal pericytes. Mol Med 8:546–550PubMed
47.
go back to reference Yamagishi S, Inagaki Y, Amano S, Okamoto T, Takeuchi M, Makita Z (2002) Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties. Biochem Biophys Res Commun 296:877–882CrossRefPubMed Yamagishi S, Inagaki Y, Amano S, Okamoto T, Takeuchi M, Makita Z (2002) Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties. Biochem Biophys Res Commun 296:877–882CrossRefPubMed
48.
go back to reference Iozzo RV, San Antonio JD (2001) Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J Clin Invest 108:349–355CrossRefPubMed Iozzo RV, San Antonio JD (2001) Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J Clin Invest 108:349–355CrossRefPubMed
49.
go back to reference Vlodavsky I, Miao HQ, Medalion B, Danagher P, Ron D (1996) Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev 15:177–186PubMed Vlodavsky I, Miao HQ, Medalion B, Danagher P, Ron D (1996) Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev 15:177–186PubMed
50.
go back to reference Boyd-White J, Williams JC Jr (1996) Effect of cross-linking on matrix permeability. A model for AGE-modified basement membranes. Diabetes 45:348–353PubMed Boyd-White J, Williams JC Jr (1996) Effect of cross-linking on matrix permeability. A model for AGE-modified basement membranes. Diabetes 45:348–353PubMed
51.
go back to reference Mott JD, Khalifah RG, Nagase H, Shield CF 3rd, Hudson JK, Hudson BG (1997) Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility. Kidney Int 52:1302–1312PubMed Mott JD, Khalifah RG, Nagase H, Shield CF 3rd, Hudson JK, Hudson BG (1997) Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility. Kidney Int 52:1302–1312PubMed
52.
go back to reference Sensi M, Tanzi P, Bruno MR et al. (1989) Nonenzymic glycation of isolated human glomerular basement membrane changes its physicochemical characteristics and binding properties. Nephron 52:222–226PubMed Sensi M, Tanzi P, Bruno MR et al. (1989) Nonenzymic glycation of isolated human glomerular basement membrane changes its physicochemical characteristics and binding properties. Nephron 52:222–226PubMed
53.
go back to reference Kuzuya M, Satake S, Ai S et al. (1998) Inhibition of angiogenesis on glycated collagen lattices. Diabetologia 41:491–499CrossRefPubMed Kuzuya M, Satake S, Ai S et al. (1998) Inhibition of angiogenesis on glycated collagen lattices. Diabetologia 41:491–499CrossRefPubMed
54.
go back to reference Beltramo E, Pomero F, Allione A, D’Alu F, Ponte E, Porta M (2002) Pericyte adhesion is impaired on extracellular matrix produced by endothelial cells in high hexose concentrations. Diabetologia 45:416–419CrossRefPubMed Beltramo E, Pomero F, Allione A, D’Alu F, Ponte E, Porta M (2002) Pericyte adhesion is impaired on extracellular matrix produced by endothelial cells in high hexose concentrations. Diabetologia 45:416–419CrossRefPubMed
55.
go back to reference Beltramo E, Buttiglieri S, Pomero F et al. (2003) A study of capillary pericyte viability on extracellular matrix produced by endothelial cells in high glucose. Diabetologia 46:409–415PubMed Beltramo E, Buttiglieri S, Pomero F et al. (2003) A study of capillary pericyte viability on extracellular matrix produced by endothelial cells in high glucose. Diabetologia 46:409–415PubMed
56.
go back to reference Giardino I, Edelstein D, Brownlee M (1994) Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes. J Clin Invest 94:110–117PubMed Giardino I, Edelstein D, Brownlee M (1994) Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes. J Clin Invest 94:110–117PubMed
57.
go back to reference Taylor CC (2000) Platelet-derived growth factor activates porcine thecal cell phosphatidylinositol-3-kinase-Akt/PKB and ras-extracellular signal-regulated kinase-1/2 kinase signaling pathways via the platelet-derived growth factor-beta receptor. Endocrinology 141:1545–1553CrossRefPubMed Taylor CC (2000) Platelet-derived growth factor activates porcine thecal cell phosphatidylinositol-3-kinase-Akt/PKB and ras-extracellular signal-regulated kinase-1/2 kinase signaling pathways via the platelet-derived growth factor-beta receptor. Endocrinology 141:1545–1553CrossRefPubMed
Metadata
Title
Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor
Authors
A. W. Stitt
S.-J. Hughes
P. Canning
O. Lynch
O. Cox
N. Frizzell
S. R. Thorpe
T. G. Cotter
T. M. Curtis
T. A. Gardiner
Publication date
01-10-2004
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 10/2004
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1523-3

Other articles of this Issue 10/2004

Diabetologia 10/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.